| INTRODUCTION
Turner syndrome (TS) is one of the most common genetic conditions characterized by the partial or complete lack of one X chromosome, affecting 1 in every 2500 female live births. 1 The age of diagnosis of TS varies greatly from the prenatal period through to middle age. In childhood, common presenting features include lymphoedema, short stature, recurrent otitis media or congenital heart defects. 2, 3 During adolescence a common route to diagnosis is presentation with primary amenorrhoea and delayed puberty. In older age groups, the diagnosis may be made following investigation for secondary amenorrhoea or infertility.
TS is associated with a variety of morbidities which can affect nearly every body system and become increasingly prevalent during
| SUBJECTS AND METHODS
The clinics at UCLH have records of 782 women with TS of whom 20 (2.5%) declined consent for their data to be included for research.
For the remaining 762 individuals, the inclusion criteria for this report were a confirmed diagnosis of TS and a recorded TS karyotype. In the adult setting, the details of the original diagnosis are not always retrievable. Where possible the original karyotype was sought with the assistance of the three nearest regional cytogenetic centres. In some instances, the karyotype was repeated in the adult clinic. In all instances, karyotype analysis was performed at National Health Service (NHS) cytogenetic facilities, where blood cells were cultured to at least a 30 cell count and examined using routine karyotype staining. No secondary cell lines were examined for mosaicism. Karyotypes were available in 656 (78.1%) of the cohort. To assess potential bias from missing karyotype data, we performed an assessment of available data on these subjects in three parameters; amenorrhoea, aortic valve type and height in order to determine how they may differ from those with a karyotype.
For the purposes of this study, we focused on women who were categorized into five major karyotype groups which were of sufficient size to allow data comparison (Table 1) . These groups were as follows:
45,X; 45,X/46,XX mosaicism; isochromosome X including mosaicism-45,X,i(Xq) and 45,X/46,X,i(Xq); 45,X/46,XY mosaicism and ring X mosaicism-45,X/46,X,r(X) ( Data were analysed using statistical software SPSS version 22
(SPSS Inc., Chicago, IL, USA). Continuous variables were converted into a binary format, allocating those in the upper quartile to represent those within the cohort with more adverse outcomes compared to the lowest three quartiles combined. In the case of bone mineral density T-scores, the lower quartile was taken as an adverse outcome. Table 2 summarizes the local reference ranges for biochemical blood tests and clinic investigations along with the quartile cut point for "at-risk" definition. We sought to establish the pattern of adverse outcomes for each karyotype group compared to the classic 45,X group. We, therefore, nominated the 45,X group as a reference to compare each of the other four karyotype groups separately.
Our aim was to define how each of the four karyotype groups differ from the 45,X group. Therefore for each variable, a χ 2 analysis was performed four times, one for each karyotype group. The prevalence was taken to be the percentage in each of the karyotype subgroups receiving treatment. In the case of autoimmunity, a positive test result was taken to calculate prevalence. We used a P-value of ≤.05 to identify group differences. ANOVA analysis was applied to continuous variables such as height to test for differences to each group against the 45,X group.
Further analysis of nonmosaic isochromosome X, 46,X,i(Xq), was undertaken separately to investigate the possible effects of Xq triploidy. The study was approved by the Chelsea Research Ethics Committee, reference LO/ 2174; informed consent was taken from all subjects.
| RESULTS
The karyotype subgroups for the 611 women with a recorded karyotype are shown in (Table 1) . Of the five major karyotype groups, 45,X was the most common (41.6%) ( Table 1) .
We compared basic parameters in 611 women with a known karyotype against 171 for whom karyotype was missing. Features of the main paediatric outcomes are presented in Table 3 .
The mean age of diagnosis was 10. Spine T-score* ≤−2.5 ≥−1.8
The quartile cut point for those in the top quartile or bottom quartile in the case of bone T-score indicates the "at-risk" range. In most instances, the quartile cut point approximates to the upper boarder of the reference range.
T A B L E 3 Shows the paediatric outcomes for the 611 adult women with TS at University College London Hospital (UCLH) spontaneous menstrual cycles at the last visit was 11%. A total of 69 pregnancies were recorded for this cohort.
Common comorbidities developing in adulthood are presented in Table 4 . Current age ranged between 18.1 and 70.3 years old for the total cohort with a mean of 32.9 years old (Table 3) .
| Results relating to specific karyotype subgroups
To present outcome differences between karyotype subgroups, we have used the 45,X group as reference to which the other groups were compared individually.
| 45,X/46,XX
As expected the 45,X/46,XX mosaic group had the lowest incidence of comorbidities. Significant differences were found between prevalence of primary amenorrhoea, obesity and hypertension when compared to 45,X (P≤.01) ( Tables 3 and 4) . Despite a greater likelihood of spontaneous menstruation in the mosaic subgroup there was no protection against osteoporosis. The group were younger at assessment compared to other groups (Table 3 ).
| Isochromosome (Xq)
We found the isochromosome (Xq) karyotype group to closely match the outcomes of the 45,X group except for a reduced prevalence of bicuspid valve and upper quartile ASI (Table 4) . We did not find an excess of severe hearing loss, congenital heart disease, diabetes mellitus or autoimmunity when compared to 45,X ( Participants' most recent visit data were used to take a cross-section. For continuous variables, the upper quartile was allocated to represent the "at-risk" group excluding bone mineral density T-scores were the lower quartile was used. A χ 2 analysis was used to compare the prevalence of subjects in the "at-risk" group in the 45,X to each of the four karyotype subgroups using a χ 2 analysis. 
| 45,x/46,xy
We found that the XY karyotype group had the lowest incidence of (Tables 3and   4) . In all other respects, this group was not significantly different to the 45,X group.
| Ring chromosome X (r,X)
The ring chromosome group was the only group to show a more se- 
| Clinical significance of proportion of 45,X cell line in mosaic forms
In the mosaic groups, the clinical significance of the degree of mosaici- 
| DISCUSSION
The aim of this first analysis from Turner Syndrome Life Course Project was to identify the relationship between karyotype and clinical outcomes of adult women with TS. We found several novel associations including a profile of metabolic syndrome in the r(X) group and a relative protection from thyroid disease and severe hearing loss in those with 45,X/46,XY mosaicisim. The XY and ring mosaic subgroups saw relative cardiovascular disease protection; however, the isochromosome (Xq) saw the largest decreased incidence of cardiovascular disease.
The distribution of five major karyotype subgroups is similar to that found in other cohorts except in the case of the ring chromosome and XY mosaic groups which are less frequently reported.
Several studies have sought to characterize features of karyotype subgroups in subjects with TS. Some smaller studies were confined only to the most common groups namely 45,X versus 45,X mosaics and isochromosome (Xq). 10, 13 Some larger studies focused on only paediatric subjects, 3 while others report outcomes based on population data repositories. 4, 5 Clinic-based ascertainment, such as that presented here, is likely to show a more severe phenotype compared to population studies but the data maybe more representative of the real-life expectations from other clinics. Table 5 summarizes the characteristics of previous large cohort studies compared to the ULCH cohort.
In most instances, 45,X is the most severely affected of all the TS karyotypes and is associated with the highest incidence of comorbidities and mortality. 5 Previous research has concluded that this is the result of the complete lack of one X chromosome causing haploinsufficiency of X chromosome genes. [4] [5] [6] This was reflected in the current study data which showed an earlier age of diagnosis for those with 45,X compared to other karyotype groups and especially compared to T A B L E 5 A summary for the characteristics of large cohort studies of women with TS noting the method of ascertainment and age range when documented those with 45,X/46,XX who had the latest age of diagnosis. This trend has previously been described.
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The isochromosome (Xq) karyotype has been reported to have increased incidence of hearing loss, 14 autoimmunity, 9 congenital heart disease 12 and diabetes mellitus. 11 The current study failed to show any of these associations. The triploidy of Xq in isochromosome has been hypothesized to be associated with diabetes mellitus and congenital heart disease risk. 11, 12 To investigate the possible effect of gene dosage in isochromosome (Xq) further we analysed a subgroup of 28 cases with nonmosaic isochromosome (Xq) which eliminated noise produced by mosaicisim. We can conclude that putative risks associated with the isochromosome (Xq) do not seem to translate to overt comorbidity especially in regard to severe hearing loss, congenital heart disease, autoimmunity and diabetes mellitus.
The differences in our data from previous reports could be accounted for by the method of assessment of hearing deficit. For audiology outcomes we used the use of hearing aid use which may be less sensitive that formal audiology testing. Similarly, our use of treatment of diabetes mellitus and elevated HbAc1 as definition of diabetes mellitus status will be less sensitive than systematic oral glucose tolerance testing. In the case of autoimmunity, the variable defined by treated hypothyroidism is robust and so we conclude that earlier reports of association between isochromosome (Xq) and autoimmunity in small study groups were likely to be a false positive finding that was eliminated in this larger cohort.
One of the novel observations in the current study is the finding that those with an XY mosaic karyotype were less likely to develop hypothyroidism and had the lowest incidence of severe hearing loss and aortic root dilatation. The low incidence of hypothyroidism in the group mirrors the male-to-female ratio of this condition in the general population. We note, however, that the prevalence of autoimmune thyroid disease in this subgroup is much greater than for men and so the 45,X cell line continues to influence autoimmunity risk.
A second novel finding is the association of features of metabolic syndrome in those with the r(X) karyotype as indicated by the increased incidence of elevated HbAc1 and ALT levels-the latter likely to represent fatty liver change. Parallel changes in related factors of excess diabetes mellitus, elevated GGT and blood pressure in this group did not achieve significance, although these were notably in the same direction of risk. We postulate that smaller sample sizes of previous studies resulted in r(X) group not being assessed as a separate entity. Therefore, an underlying metabolic syndrome had not been identified previously. [3] [4] [5] 10, 11 In other respects, the r(X) subgroup had a lower incidence of some cardinal feature of TS. In particular, they had a lower incidence of bicuspid valve and hearing loss, which are thought to be secondary to lymphatic maldevelopment.
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As a result of these observations of the ring chromosome we propose that risk stratification for the ring chromosome could be further refined. For instance, the XIST region will help determine whether the ring chromosome is in its active or inactive state, as the XIST leads to X inactivation when transcribed. Therefore, the inclusion or exclusion of this region may lead to associations between comorbidities and ring chromosome through abnormal gene dosage if the X is unable to deactivate. 16, 17 To test for possible bias resulting from missing data, we analysed whether those in whom we did not have karyotype data differed from the study group. For the most part, the missing karyotype group was similar to the study group, although a milder phenotype was suggested by a decreased prevalence of primary amenorrhoea. There are several other sources of potential bias in our study. First, UCLH is a tertiary referral hospital providing specialist care. Therefore, findings from this cohort may not necessarily reflect the wider population of women with TS. Second, we are aware that an increasing number of women with TS are referred to our centre for fertility advice and might have a milder phenotype than in a previous era.
We conclude that TS-associated karyotypes are predisposing factor to increased risk of age-related disease. In the case of the isochromosome (Xq), current data are conflicting; therefore, further studies are required to clarify the associations between the isochromosome (Xq) and comorbidities. The novel associations of the ring chromosome found in this study should provide a basis for future research with a focus towards gene dosage effects of this karyotype.
